"Performance" Jacobson Pharma's interim net profit is HKD 142 million, an increase of 1.2%, with a dividend of 4.25 cents

JACOBSON PHARMA (02633.HK) announced its interim results for the six months ending in September, with revenue of HKD 767 million, a year-on-year decrease of 5.4%. It recorded a net profit of HKD 142 million, an increase of 1.2%, with earnings per share of HKD 0.0712. The interim dividend is HKD 0.0425, compared to HKD 0.035 in the same period last year